| Literature DB >> 30721776 |
Mingxiao Ning1, Panpan Wei1, Hui Shen2, Xihe Wan2, Mingjian Jin3, Xiangqian Li4, Hao Shi4, Yi Qiao2, Ge Jiang2, Wei Gu5, Wen Wang1, Li Wang6, Qingguo Meng7.
Abstract
Enterocytozoon hepatopenaei (EHP) causes hepatopancreatic microsporidiosis (HPM) in shrimp. HPM is not normally associated with shrimp mortality, but is associated with significant growth retardation. In this study, the responses induced by EHP were investigated in hepatopancreas of shrimp Litopenaeus vannamei using proteomics and metabolomics. Among differential proteins identified, several (e.g., peritrophin-44-like protein, alpha2 macroglobulin isoform 2, prophenoloxidase-activating enzymes, ferritin, Rab11A and cathepsin C) were related to pathogen infection and host immunity. Other proteomic biomarkers (i.e., farnesoic acid o-methyltransferase, juvenile hormone esterase-like carboxylesterase 1 and ecdysteroid-regulated protein) resulted in a growth hormone disorder that prevented the shrimp from molting. Both proteomic KEGG pathway (e.g., "Glycolysis/gluconeogenesis" and "Glyoxylate and dicarboxylate metabolism") and metabolomic KEGG pathway (e.g., "Galactose metabolism" and "Biosynthesis of unsaturated fatty acids") data indicated that energy metabolism pathway was down-regulated in the hepatopancreas when infected by EHP. More importantly, the changes of hormone regulation and energy metabolism could provide much-needed insight into the underlying mechanisms of stunted growth in shrimp after EHP infection. Altogether, this study demonstrated that proteomics and metabolomics could provide an insightful view into the effects of microsporidial infection in the shrimp L. vannamei.Entities:
Keywords: Enterocytozoon hepatopenaei; Hepatopancreatic microsporidiosis; Litopenaeus vannamei; Metabolomics; Proteomics
Mesh:
Substances:
Year: 2019 PMID: 30721776 DOI: 10.1016/j.fsi.2019.01.051
Source DB: PubMed Journal: Fish Shellfish Immunol ISSN: 1050-4648 Impact factor: 4.581